the impact of local treatment in patients with newly diagnosed metastatic prostate cancer
Published 7 years ago • 282 plays • Length 10:55Download video MP4
Download video MP3
Similar videos
-
14:42
local therapy - managing locoregional complications in metastatic prostate cancer
-
19:50
new standards of care for advanced prostate cancer
-
17:44
new approaches to metastatic hormone sensitive prostate cancer
-
20:17
role of local rt in the metastatic setting
-
18:18
management of the primary in locally advanced and oligometastatic disease
-
27:50
new concepts in adt
-
16:26
patient selection in metastatic hormone-sensitive prostate cancer (mhspc)
-
4:00
empowering patients: understanding prostate cancer and treatment innovations
-
5:33
pca commentary for october 2021: therapy of the primary tumor in newly diagnosed mhspc
-
7:50
nccn guidelines for treatment of localized prostate cancer
-
22:00
debate: prostate cancer patients should/should not get chemo and adt as a standard of care
-
24:40
guidelines based management of localized and locally advanced rcc
-
24:37
the role of therapeutic layering in optimizing treatment for patients with prostate cancer
-
5:25
local treatment: radiation therapy (primary /- lymph nodes)
-
51:25
11.23.2020 urology covid didactics - management of advanced prostate cancer
-
10:00
biochemical recurrence after local therapy: assessment and management
-
26:54
fluciclovine (18f) pet/ct impact on clinical management of recurrent prostate cancer
-
16:03
burning questions and controversies in the management of advanced prostate cancer patients
-
30:58
challenging cases in advanced prostate cancer- mhspc